Back to Search

AJOVY for Long-term Migraine Treatment

Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

Recruiting Observational Study
Migraine Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Otsuka Pharmaceutical Co., Ltd. · Industry
Who this trial is looking for

This trial is looking for patients with migraines to study the long-term safety of the drug AJOVY. Participants will receive the medication under normal conditions and share information about their experiences.

Are You a Good Fit for This Trial?

You may not be able to join if

  • I have a known hypersensitivity to components of AJOVY

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To evaluate the long-term safety of AJOVY in patients under actual use conditions and to specifically evaluate cardiovascular events. In addition, information on efficacy will be collected.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Exclusion Criteria: * patients with a known hypersensitivity to components of AJOVY
Contacts

Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd

+81-6-6943-7722

komaniwa.satoshi@otsuka.jp

CONTACT

NCT ID: NCT05342493 Source: ClinicalTrials.gov